Influenza and other respiratory viruses · 2026
Influenza Vaccination Effectiveness in Preventing Hospitalization of Adults With Underlying Medical Conditions: A Multicentre Case-Control Study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Toledo Diana, Soldevila Núria, Galan Juan Carlos, Godoy Pere, Morales-Suarez-Varela María, Rodriguez-Suárez Marta, Grau María, Fernández-Villa Tania, Morillo Aurea, Navarro Gemma, Chamorro Judith, Domínguez Angela, Project PI19/00354 Working Group
Аннотация
BACKGROUND: Seasonal influenza, especially in persons with underlying medical conditions, is a substantial global burden. Influenza vaccination effectiveness (VE) varies annually, requiring continuous evaluation due to evolving viruses and vaccination coverages. Our aim was to investigate influenza VE in preventing hospitalization for confirmed influenza among people aged 15-64 years with underlying medical conditions.
METHODS: We conducted a multicentre case-control study across 17 Spanish hospitals in hospitalized patients aged 15-64 years with underlying medical conditions in three influenza seasons. Influenza VE was estimated using two types of controls: test-negative controls and non-acute respiratory infection controls. Data on demographics, underlying medical conditions, vaccination status and clinical outcomes were collected. Adjusted VE was analysed using multivariable logistic regression models.
RESULTS: Recruited were 1220 hospitalized adults with underlying medical conditions, of whom 25.2% were vaccinated. VE varied by season, age group, and virus subtype. Statistically significant protection was observed for all seasons jointly against influenza A(H3N2) subtype, whereas VE estimates for specific seasons and subtypes were not significant.
CONCLUSIONS: These findings underscore the importance of continuous VE monitoring and tailored vaccination strategies to protect adults with underlying medical conditions and highlight low seasonal influenza vaccination coverage in this population. Influenza seasonal vaccination should be improved in people aged 15-64 years with underlying medical conditions.
METHODS: We conducted a multicentre case-control study across 17 Spanish hospitals in hospitalized patients aged 15-64 years with underlying medical conditions in three influenza seasons. Influenza VE was estimated using two types of controls: test-negative controls and non-acute respiratory infection controls. Data on demographics, underlying medical conditions, vaccination status and clinical outcomes were collected. Adjusted VE was analysed using multivariable logistic regression models.
RESULTS: Recruited were 1220 hospitalized adults with underlying medical conditions, of whom 25.2% were vaccinated. VE varied by season, age group, and virus subtype. Statistically significant protection was observed for all seasons jointly against influenza A(H3N2) subtype, whereas VE estimates for specific seasons and subtypes were not significant.
CONCLUSIONS: These findings underscore the importance of continuous VE monitoring and tailored vaccination strategies to protect adults with underlying medical conditions and highlight low seasonal influenza vaccination coverage in this population. Influenza seasonal vaccination should be improved in people aged 15-64 years with underlying medical conditions.